Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

Rhea-AI Summary

Regulus Therapeutics (Nasdaq: RGLS), a biopharmaceutical company specializing in microRNA-targeted medicine development, has announced its upcoming participation at the Leerink Partners 2025 Global Healthcare Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, March 11th at 3:40 p.m. ET.

Investors and interested parties can access both the live presentation and its replay through the 'Events and Presentations' section on Regulus' investor relations website. The presentation recording will remain accessible for 90 days following the event.

SAN DIEGO, March 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11^th at 3:40 p.m. ET.

The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.

About Regulus
Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in San Diego, CA.

View original content to download multimedia:https://www.prnewswire.com/news-releases/regulus-therapeutics-to-present-at-the-leerink-partners-2025-global-healthcare-conference-302390551.html

SOURCE Regulus Therapeutics Inc.

FAQ

When is Regulus Therapeutics (RGLS) presenting at the Leerink Partners 2025 Conference?

Regulus Therapeutics will present on Tuesday, March 11th, 2025, at 3:40 p.m. ET.

How long will the RGLS Leerink Conference presentation replay be available?

The presentation replay will be available for 90 days following the event date.

Where can investors access Regulus Therapeutics' (RGLS) Leerink Conference presentation?

Investors can access the presentation through the 'Events and Presentations' section at https://ir.regulusrx.com/events

What type of presentation will RGLS deliver at the Leerink Partners Conference?

Regulus Therapeutics management team will participate in a fireside chat format presentation.